<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-82205</identifier>
<setSpec>1130-0108</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Pegylated interferon induced interstitial pneumonitis in a patient with hepatitis C infection</dc:title>
<dc:description xml:lang="en">Pegylated interferon and ribavirin is the treatment of choice in patients with chronic hepatitis C infection. The most common side effects of interferon therapy are flu-like symptoms and psychiatric disorders. Pneumonitis is a less frequent complication associated with non-negligible mortality. We herein report a case of interferon associated pneumonitis in a patient with non-severe clinical symptoms and a normal chest radiography. Physicians should be aware of this entity during the differential diagnosis of respiratory symptoms in patients receiving treatment with interferon due to its high morbimortality and good resolution and outcome after drug withdrawal(AU)</dc:description>
<dc:creator>Jara Chinarro, B</dc:creator>
<dc:creator>García de Casasola, G</dc:creator>
<dc:creator>Gámez Díez, S</dc:creator>
<dc:creator>orres Macho, J</dc:creator>
<dc:creator>Suárez Aliaga, B</dc:creator>
<dc:creator>Cuenca Morón, B. de</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El interferón pegilado asociado a ribavirina es el tratamiento de elección en los pacientes con infección por hepatitis C crónica. Los efectos secundarios más comunes son los síntomas gripales y las alteraciones psiquiátricas. La neumonitis es una complicación poco frecuente, pero se asocia con una mortalidad no despreciable. Presentamos el caso clínico de un paciente con neumonitis intersticial asociada a interferón que presentaba signos y síntomas clínicos sutiles y una radiografía de tórax sin alteraciones. Se debe de tener presente esta entidad en el diagnóstico diferencial de los síntomas respiratorios en pacientes que reciben tratamiento con interferón debido a su elevada morbi-mortalidad y a su evolución favorable tras la retirada del fármaco(AU)</dc:description>
<dc:source>Rev Esp Enferm Dig;102(10): 606-608, oct. 2010. ilus</dc:source>
<dc:identifier>ibc-82205</dc:identifier>
<dc:title xml:lang="es">Neumonitis intersticial secundaria a tratamiento con interferón pegilado</dc:title>
<dc:subject>^d4479^s22012</dc:subject>
<dc:subject>^d33344^s22016</dc:subject>
<dc:subject>^d33344^s22057</dc:subject>
<dc:subject>^d28418</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d31333^s22067</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d31333^s22032</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d23481^s22074</dc:subject>
<dc:subject>^d29469^s22073</dc:subject>
<dc:subject>^d31333^s22016</dc:subject>
<dc:subject>^d12663^s22073</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d32824^s22074</dc:subject>
<dc:subject>^d6493^s22021</dc:subject>
<dc:subject>^d32824^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>201010</dc:date>
</metadata>
</record>
</ibecs-document>
